ID   OANC1
AC   CVCL_W891
DR   cancercelllines; CVCL_W891
DR   Cosmic; 2030752
DR   Wikidata; Q54931680
RX   PubMed=24077944;
CC   Doubling time: ~48 hours (PubMed=24077944).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000024850; Zygosity=Homozygous (PubMed=24077944).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Homozygous (PubMed=24077944).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): PubMed=24077944
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 13
ST   D18S51: 19
ST   D21S11: 31
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C7027; Barrett adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 13
//
RX   PubMed=24077944; DOI=10.1007/s10620-013-2882-8;
RA   Clemons N.J., Do H.-D., Fennell C., Deb S., Fellowes A., Dobrovic A.,
RA   Phillips W.A.;
RT   "Characterization of a novel tumorigenic esophageal adenocarcinoma
RT   cell line: OANC1.";
RL   Dig. Dis. Sci. 59:78-88(2014).
//